Latest Oncolytic virus Stories
First Trial to Combine These Investigational Immunotherapies for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases THOUSAND OAKS, Calif., June 2, 2015 /PRNewswire/ --
Companies Also Plan to Initiate Phase 3 Trial in Combination for Advanced Melanoma THOUSAND OAKS, Calif.
Talimogene Laherparepvec First Oncolytic Immunotherapy to Demonstrate Therapeutic Benefit for Patients With Advanced Melanoma THOUSAND OAKS, Calif., May 26, 2015 /PRNewswire/ --
--Collaboration Combines Companies' Expertise in Oncolytic Virus Therapy and Targeted Drug Delivery-- LOWELL, Mass.
CALGARY, May 7, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
CALGARY, May 6, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
FACIT partners with Ontario researchers to create new company TORONTO, May 4, 2015 /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) and its partners are pleased
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
CALGARY, April 20, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
- The parings of haberdine; also, any kind of fragments.